The invention relates to the use of an antifungal active substance and an epithelialcell or endothelial cell adhesion inhibitor for producing a combination medicamentfor the topical treatment of candida mycotic infections such as vulvovaginalcandidiasis, oropharyngeal candidiasis (oral thrush), diaper dermatitis(diaper thrush), and intertriginous (candida) excema.